You have 9 free searches left this month | to do more
Showing 1 - 25 of
4,771 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Completed
  • Hematologic Malignancies
  • RD13-01 cell infusion
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
2022-01-08
Jan 8, 2022
C
Not yet recruiting
  • Locally Advanced Solid Tumor
  • +2 more
  • (no location specified)
2021-08-25
Aug 25, 2021
U
Completed
  • Hematologic Malignancies
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Hospital
2021-12-03
Dec 3, 2021
J
Active, not recruiting
  • Hematologic Malignancies
  • CliniMACs
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
2022-04-04
Apr 4, 2022
R
Recruiting
  • Sexuality
  • +4 more
  • Sexual Health
  • Copenhagen, Denmark
    Kristina Nørskov
2022-02-02
Feb 2, 2022
S
Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-02-14
Feb 14, 2022
C
Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
2021-09-14
Sep 14, 2021
A
Recruiting
  • Hematologic Malignancies
  • Jacksonville, Florida
  • +4 more
2022-02-28
Feb 28, 2022
Z
Recruiting
  • Hematologic Malignancies
  • Houston, Texas
    MD Anderson
2021-05-12
May 12, 2021
N
Recruiting
  • Myelodysplasia
  • Hematologic Malignancy
  • CliniMACS® TCRαβ/CD19 Combined Depletion System
  • Columbus, Ohio
    Nationwide Children's Hospital
2022-01-11
Jan 11, 2022
K
Not yet recruiting
  • Cancer
  • M-Tech
  • Usual Care
  • Rochester, New York
    University of Rochester
2022-03-09
Mar 9, 2022
J
Completed
  • Hematologic Malignancies
  • Houston, Texas
    MD Anderson Cancer Center
2021-02-12
Feb 12, 2021
9
Recruiting
  • B-cell Lymphoma
  • CTA30X UCAR-T injection
  • Kunming, Yunnan, China
    No.212 Daguan Road, Xishan District
2021-08-15
Aug 15, 2021
S
Recruiting
  • Relapsed or Refractory B-cell Hematologic Malignancies
  • Beijing, Beijing, China
  • +1 more
2021-04-26
Apr 26, 2021
S
Terminated
  • Hematologic Malignancies
  • IPI-145 (duvelisib)
  • New York, New York
  • +3 more
2021-03-15
Mar 15, 2021
W
Not yet recruiting
  • Pediatric Hematologic Malignancies
  • αβ-TCR/CD19 cell depleted haploidentical hematopoietic stem cell graft
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-08-11
Aug 11, 2021
E
Recruiting
  • Acute Myeloid Leukemia
  • Dallas, Texas
  • +1 more
2022-03-14
Mar 14, 2022
E
Recruiting
  • Hematologic Neoplasms
  • Milan, Italy
    European Institute of Oncology
2021-09-24
Sep 24, 2021
P
Recruiting
  • CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
  • T cell injection targeting CD7 chimeric antigen receptor
  • Hefei, Anhui, China
    PersonGen.Anke Cellular Therapeutice Co., Ltd.
2021-12-24
Dec 24, 2021
M
Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-10-28
Oct 28, 2021
M
Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Data Capture
  • Electronic Medical Record
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-23
Nov 23, 2021
M
Recruiting
  • Monoclonal B-Cell Lymphocytosis
  • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    2022-02-10
    Feb 10, 2022
    U
    Recruiting
    • Relapsed or Refractory Hematologic Malignancies
    • Chicago, Illinois
      University of Illinois Cancer Center
    2022-01-28
    Jan 28, 2022
    C
    Recruiting
    • Leukemia
    • +2 more
    • Alpha Beta T cell depletion
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    2021-10-27
    Oct 27, 2021
    U
    Terminated
    • Hematologic Cancer
    • Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
    • La Jolla, California
      UCSD Moore's Cancer Center
    2022-01-31
    Jan 31, 2022